Daniel M. Skovronsky
Chief Scientific and Product Officer; President, Lilly Research Laboratories · Eli Lilly and Company
Compiled from public sources. This person has not claimed this profile. Listing does not imply membership, endorsement or availability for meetings.
Physician-scientist and pharmaceutical R&D executive responsible for Lilly's research organization and commercial product leadership across major therapeutic areas. Geographic context: United States / global.
Davos status
No verified 2027 attendance claim is available.
Last verified: 11 September 2026
Sources & verification
- https://www.weforum.org/stories/forum-institutional/live-from-davos-2026-what-to-know-on-day-5/
- https://www.lilly.com/about/leadership/daniel-skovronsky
- https://www.illumina.com/company/news-center/press-releases/2026/0e864f97-e34a-4a60-bc9e-f8c4604a045e.html
- Recorded research sources. Historical references do not confirm Davos 2027 attendance.
Record last verified: 11 September 2026. Organiser and self-reported pages are labelled as such and are not independent verification.